{"pmid":32383237,"title":"Effects of 5-alpha reductase inhibitors on lung function: a reason for discontinuation during COVID-19 pandemic?","text":["Effects of 5-alpha reductase inhibitors on lung function: a reason for discontinuation during COVID-19 pandemic?","Dermatol Ther","Kroumpouzos, George","32383237"],"journal":"Dermatol Ther","authors":["Kroumpouzos, George"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32383237","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/dth.13535","keywords":["5-alpha reductase inhibitor","covid-19","drug safety","finasteride","lung","pandemic"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666419683332456448,"score":9.490897,"similar":[{"pmid":32344304,"pmcid":"PMC7175887","title":"May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?","text":["May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?","COVID-19 pandemic is a major challenge for global and national healthcare providers. Number of new cases is continuously increasing with an emerging trend showing worse prognosis in males in comparison to females. Based on this observation, our proposed hypothesis is that 5-alpha-reductase inhibitors, that are commonly used for BPH treatment, may be one of the factors contributing to poorer prognosis in males.","Med Hypotheses","Adamowicz, Jan","Juszczak, Kajetan","Drewa, Tomasz","32344304"],"abstract":["COVID-19 pandemic is a major challenge for global and national healthcare providers. Number of new cases is continuously increasing with an emerging trend showing worse prognosis in males in comparison to females. Based on this observation, our proposed hypothesis is that 5-alpha-reductase inhibitors, that are commonly used for BPH treatment, may be one of the factors contributing to poorer prognosis in males."],"journal":"Med Hypotheses","authors":["Adamowicz, Jan","Juszczak, Kajetan","Drewa, Tomasz"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32344304","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.mehy.2020.109751","topics":["Treatment","Mechanism","Diagnosis"],"weight":1,"_version_":1666138495082561536,"score":100.43844},{"pmid":32250244,"pmcid":"PMC7198232","title":"Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients.","text":["Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients.","The discovery of angiotensin converting enzyme-2 (ACE-2) as the receptor for SARS- CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) has implicated the renin-angiotensin-aldosterone system in acute respiratory distress syndrome (ARDS) and respiratory failure in patients with coronavirus disease-19 (COVID-19). The angiotensin converting enzyme-1-angiotensin II-angiotensin AT1 receptor pathway contributes to the pathophysiology of ARDS, whereas activation of the ACE-2-angiotensin(1-7)-angiotensin AT2 receptor and the ACE-2-angiotensin(1-7)-Mas receptor pathways have been shown to be protective. Here we propose and discuss therapeutic considerations how to increase soluble ACE-2 in plasma in order for ACE-2 to capture and thereby inactivate SARS-CoV-2. This could be achieved by administering recombinant soluble ACE-2. We also discuss why and how ACEIs and ARBs provide cardiovascular, renal and also pulmonary protection in SARS-CoV-2- associated ARDS. Discontinuing these medications in COVID-19 patients may therefore potentially be harmful.","Elife","Rossi, Gian Paolo","Sanga, Viola","Barton, Matthias","32250244"],"abstract":["The discovery of angiotensin converting enzyme-2 (ACE-2) as the receptor for SARS- CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) has implicated the renin-angiotensin-aldosterone system in acute respiratory distress syndrome (ARDS) and respiratory failure in patients with coronavirus disease-19 (COVID-19). The angiotensin converting enzyme-1-angiotensin II-angiotensin AT1 receptor pathway contributes to the pathophysiology of ARDS, whereas activation of the ACE-2-angiotensin(1-7)-angiotensin AT2 receptor and the ACE-2-angiotensin(1-7)-Mas receptor pathways have been shown to be protective. Here we propose and discuss therapeutic considerations how to increase soluble ACE-2 in plasma in order for ACE-2 to capture and thereby inactivate SARS-CoV-2. This could be achieved by administering recombinant soluble ACE-2. We also discuss why and how ACEIs and ARBs provide cardiovascular, renal and also pulmonary protection in SARS-CoV-2- associated ARDS. Discontinuing these medications in COVID-19 patients may therefore potentially be harmful."],"journal":"Elife","authors":["Rossi, Gian Paolo","Sanga, Viola","Barton, Matthias"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32250244","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.7554/eLife.57278","keywords":["ace","ace inhibitor","ace inhibitors","ace-2","aceis","arbs","ards","acute respiratory distress syndrome","covid-19","raas","sars","sars-cov-2","angiotensin","angiotensin receptor antagonists","angiotensin receptor blocker","angiotensin-converting enzyme-1","angiotensin-converting enzyme-2","arterial hypertension","cardiovascular","coronavirus","human biology","infection","medicine","renin-angiotensin-aldosterone system","therapy","treatment","virus"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138490960609281,"score":65.28017},{"pmid":32283245,"pmcid":"PMC7151476","title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated.","text":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated.","J Am Acad Dermatol","Wambier, Carlos Gustavo","Goren, Andy","32283245"],"journal":"J Am Acad Dermatol","authors":["Wambier, Carlos Gustavo","Goren, Andy"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32283245","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jaad.2020.04.032","keywords":["5-alpha reductase","ace2","covid-19","sars-cov-2","tmprss2","androgen receptor","androgenetic alopecia","angiotensin converting enzyme 2","antiandrogen therapy","dutasteride","finasteride","human skin","retinoids","transmembrane protease serine 2"],"topics":["Mechanism"],"weight":1,"_version_":1666138491511111681,"score":62.82795},{"pmid":32436403,"title":"Evidence that Renin-Angiotensin System Inhibitors Should not be Discontinued Due to the COVID-19 Pandemic.","text":["Evidence that Renin-Angiotensin System Inhibitors Should not be Discontinued Due to the COVID-19 Pandemic.","Hypertension","Carey, Robert M","Wang, Ji-Guang","32436403"],"journal":"Hypertension","authors":["Carey, Robert M","Wang, Ji-Guang"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32436403","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1161/HYPERTENSIONAHA.120.15263","keywords":["covid-19"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667521393528406016,"score":59.04462},{"pmid":32397951,"title":"The expression level of angiotensin-converting enzyme 2 determine the severity of COVID-19: lung and heart tissue as targets.","text":["The expression level of angiotensin-converting enzyme 2 determine the severity of COVID-19: lung and heart tissue as targets.","Researchers have reported some useful information about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which leads to coronavirus disease 2019 (COVID-19). Several studies have been performed in order to develop antiviral drugs, from which a few have been prescribed to patients in addition, several diagnostic tests have been designed to accelerate the process of identifying and treating COVID-19. The surface of host cells is covered by some receptors, known as ACE2, which mediates the binding and entry of CoV. After entering, the viral RNA interrupts the cell proliferation system to activate self-proliferation.However, having all the information about the prevalence of the SARS-COV-2, it is not still clear which factors determine the severity of lung and heart function impairment induced by COVID-19. A major step in exploring SARS-COV-2 pathogenesis is to determine the distribution of ACE2 proteins on tissue surface. In this review, the structure and origin of CoV, the role of ACE2 as a receptor of SARS-COV-2 on the surface of host cells, and the ACE2 distribution in different tissues with a focus on lung and cardiovascular system has been discussed. It was also revealed that acute and chronic cardiovascular diseases (CVDs) may result in the clinical severity of COVID-19. In conclusion, this review may provide useful information to develop some strategies to end up with a worldwide COVID-19 pandemic.","J Biomol Struct Dyn","Nejadi Babadaei, Mohammad Mahdi","Hasan, Anwarul","Haj Bloukh, Samir","Edis, Zehra","Sharifi, Majid","Kachooei, Ehsan","Falahati, Mojtaba","32397951"],"abstract":["Researchers have reported some useful information about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which leads to coronavirus disease 2019 (COVID-19). Several studies have been performed in order to develop antiviral drugs, from which a few have been prescribed to patients in addition, several diagnostic tests have been designed to accelerate the process of identifying and treating COVID-19. The surface of host cells is covered by some receptors, known as ACE2, which mediates the binding and entry of CoV. After entering, the viral RNA interrupts the cell proliferation system to activate self-proliferation.However, having all the information about the prevalence of the SARS-COV-2, it is not still clear which factors determine the severity of lung and heart function impairment induced by COVID-19. A major step in exploring SARS-COV-2 pathogenesis is to determine the distribution of ACE2 proteins on tissue surface. In this review, the structure and origin of CoV, the role of ACE2 as a receptor of SARS-COV-2 on the surface of host cells, and the ACE2 distribution in different tissues with a focus on lung and cardiovascular system has been discussed. It was also revealed that acute and chronic cardiovascular diseases (CVDs) may result in the clinical severity of COVID-19. In conclusion, this review may provide useful information to develop some strategies to end up with a worldwide COVID-19 pandemic."],"journal":"J Biomol Struct Dyn","authors":["Nejadi Babadaei, Mohammad Mahdi","Hasan, Anwarul","Haj Bloukh, Samir","Edis, Zehra","Sharifi, Majid","Kachooei, Ehsan","Falahati, Mojtaba"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32397951","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1080/07391102.2020.1767211","keywords":["ace2","covid-19","coronavirus","heart","lung","mers","sars","sars-cov-2"],"topics":["Mechanism","Diagnosis","Treatment"],"weight":1,"_version_":1666865855058673665,"score":58.738968}]}